Salivary Gland Carcinoma

• CLINICAL_TRIALS trial_result · 2026-04-02
  Clinical Trial Update: A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing [Phase 2]

  This clinical trial update describes a Phase II study of advanced salivary gland carcinoma guided by molecular typing. The study status is a…

• CLINICAL_TRIALS trial_result · 2025-11-10
  Clinical Trial Update: Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers [Phase 2]

  A Phase 2 trial evaluating darolutamide for testosterone-driven salivary gland cancers is active but not currently recruiting. The study enc…

• CLINICAL_TRIALS trial_result · 2025-09-05
  Clinical Trial Update: Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer [Phase 1]

  This document reports the completion of a Phase Ib trial evaluating erlotinib given before surgery in patients with recurrent head and neck …

• CLINICAL_TRIALS trial_result · 2024-07-30
  Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas [Phase 2]

  A Phase 2 clinical trial evaluating postoperative concurrent chemoradiotherapy for high-risk salivary gland carcinomas has completed.

• CLINICAL_TRIALS trial_result · 2024-01-18
  Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer [Phase 2]

  Phase 2 trial evaluating nivolumab and ipilimumab for metastatic/recurrent major and minor salivary gland carcinomas; status/results are not…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-01-11
  Clinical Trial Update: Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck [Phase 2]

  Phase 2 clinical trial update for nivolumab in recurrent or metastatic salivary gland carcinoma of the head and neck has completed.

• CLINICAL_TRIALS trial_result · 2020-10-22
  Clinical Trial Update: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating pembrolizumab in combination with vorinostat for recurrent, metastatic, or unresectable squamous cell ca…

• CLINICAL_TRIALS trial_result · 2019-10-29
  Clinical Trial Update: Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma [Phase 2]

  Phase 2 trial evaluating pazopanib in patients with progressive recurrent and/or metastatic salivary gland carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2017-04-18
  Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers [Phase 2]

  This ClinicalTrials.gov update reports the results of a Phase 2 trial of lapatinib in patients with recurrent and/or metastatic adenoid cyst…